• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2014

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-17 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-10-17 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-08-07 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-08-07 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
2014-06-25 17:31
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO Perfusion AB avser att genomföra en riktad emission av aktier
2014-06-25 17:31
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO intends to undertake a private placement of shares
2014-04-30 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-04-30 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-04-23 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari – mars 2014
2014-04-23 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim Report January - March 2014
2014-04-14 15:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-04-14 15:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-04-07 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2013
2014-04-07 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2013
2014-03-31 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ systemet har erhållit CE-märke
2014-03-31 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ has received CE mark
2014-03-28 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-03-28 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-03-21 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
FDA:s Expertpanelen röstade enhälligt för att XPS™ med STEEN Solution™ uppfyller kraven för HDE
2014-03-21 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE
2014-03-14 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Progress made in the NOVEL study in the USA
2014-03-14 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Framsteg i NOVEL studien i USA
2014-02-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on Operations 2013
2014-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2013
2014-01-29 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the US study with another leading transplant center
2014-01-29 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar USA-studien med ytterligare en ledande transplantationsklinik
2014-01-28 14:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2013
2014-01-28 14:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2013
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve